HomeCTMX • NASDAQ
Follow
CytomX Therapeutics Inc
Previous close
$2.19
Day range
$2.17 - $2.30
Year range
$1.04 - $2.86
Market cap
147.63M USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 26.61M | 32.22% |
Operating expense | 27.21M | 22.96% |
Net income | 837.00K | 109.54% |
Net profit margin | 3.15 | 107.22% |
Earnings per share | 0.01 | 102.38% |
EBITDA | -120.00K | 91.43% |
Effective tax rate | 56.09% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 174.51M | -9.88% |
Total assets | 201.79M | -22.65% |
Total liabilities | 249.24M | -28.10% |
Total equity | -47.45M | — |
Shares outstanding | 67.72M | — |
Price to book | -3.13 | — |
Return on assets | -0.72% | — |
Return on capital | 4.35% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 837.00K | 109.54% |
Cash from operations | -21.96M | -1,476.67% |
Cash from investing | 12.87M | -87.11% |
Cash from financing | 244.00K | 28.42% |
Net change in cash | -8.85M | -108.98% |
Free cash flow | 10.05M | -46.88% |
About
Founded
2008
Headquarters
Website
Employees
121